Please login to the form below

Not currently logged in

AXON recognised for ‘excellence in wellbeing’ by Great Place to Work

AXON team pic

Healthcare comms company wins recognition for second year in a row

Celgene’s Revlimid scores NICE approval in follicular lymphoma

NICE (National for Health and Clinical Excellence)New ‘chemotherapy-free’ treatment for patients with limited options

Lilly’s Cyramza narrowly clears FDA adcomm vote for first-line NSCLC

Eli Lilly new HQAdvisory committee voted 6-5 in favour of drug

Menlo slumps as itching drug fails mid-stage trial

Menlo TherapeuticsShares in US biotech closed down almost a third after announcement

Trial of Amgen, Servier’s heart failure drug clears interim check

Amgen flagDrug could become a $2bn product if approved

Mallinckrodt reaches tentative $1.6bn opioid settlement

MallinckrodtAgreement reached with a plaintiff's executive committee

Takeda buys coeliac disease partner PvP Biologics after phase 1 win

TakedaDeal includes upfront payment plus up to $330m in milestones

IMV preps pivotal trials for ovarian cancer T cell therapy

Drug stabilised disease in 79% of 19 evaluable patients

Clinical trial of Gilead’s coronavirus hopeful remdesivir begins in US

GileadNational Institutes of Health initiates trial of experimental drug

Stefi RucciQ&A: Stefi Rucci

PME interviews SAY Communications' joint MD and Director of Healthcare

  • Emma Sergeant Q&A: Emma Sergeant

    PME interviews president of the DAS Group of Companies in Europe

  • Vicky BramhamQ&A: Vicky Bramham

    PME interviews OPEN Health Patient & Brand Communications' managing director, PR

Latest appointments

Featured jobs

Subscribe to our email news alerts


Add my company
COUCH Health

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...

Latest intelligence

The ALS patient journey
Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
Equipping your medical affairs teams with solutions to navigate the healthcare landscape
Dr Tyler Ray, OPEN Health Medical Communications...
Protein degraders
Can protein degraders unlock ‘undruggable’ drug targets?
Exploring a new and exciting area of small-molecule drug discovery...